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The pathogenic Leishmania  cause a wide range of human disease, from cuta- 
neous lesions to generalized visceral involvement. This heterogeneity in clinical 
expression has led to attempts at classifying Leishmania  species with more preci- 
sion.  Recent biochemical technologies employing isoenzyme patterns (1),  DNA 
buoyant density (2), restriction endonuclease patterns of kinetoplast DNA (3), as 
well as immunological methods using monoclonal antibodies (mAb)  1 (4-6), have 
been described. As yet, none of these have been completely successful, used in 
isolation, in defining species specificity, and considerable crossreactivity is often 
seen. Presently, species determination is performed on the basis of three or more 
of the above methods, in addition to  the clinical characteristics of the disease 
produced in man and the biological behavior of the specific isolate in experimen- 
tal animals. 
We  have  recently reported  (7)  that  the  surface profile  of a  number of L. 
donovani  isolates with worldwide distribution displayed as a major surface com- 
ponent a glycoprotein (gp) of Mr 65,000.  It was the major antigen recognized by 
the sera of patients with visceral Leishmaniasis, and was also immunoprecipitated 
by the sera of patients with other clinical forms of Leishmaniasis (7, 9).  This is 
in keeping with the presence of major shared antigen(s) involved in protection 
to different forms of Leishmaniasis. The many instances in which crossimmunity 
between  Leishmanial  species  have  been  described  serologically and  clinically 
substantiate  this  hypothesis,  both  by  the  extensive  serological  crossreactivity 
observed in patients' sera, by the presence of natural crossprotection (9-12), and 
more recently, by the striking results with experimental crossimmunization with 
irradiated promastigotes (13-15). 
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TABLE  I 
Leishmania Species Used in This Study 
903 
Leishmania species  Human host  Strain  Reference  Abbreviation 
donovani  SU  Khartoum  19  Ld 
mexicana amazonensis  BR  Josefa  20  Lma 
mexicana mexicana  PA  1 VLM  21  Lmm 
major  SN  MHOM/SN/OO/DK  106  22  Ltm 
braziliensis guyanensis  SR  MHOM/SR/80/CUMC 1  *  Lbg 
braziliensis guyanensis  SR  Cloned from above  *  Lbg 
braziliensis braziliensis  PE  MHOM/PE/83]CUMC 2  ~  Lbb 
* Galvao-Quintao et al. ~ 
* Lbb was isolated byJ. Keithly from a 50-yr-old male ornithologist who presented with two cutaneous 
pustules on W3 right leg after collecting on the Andean slopes in Peru in 1983. Promastigotes  were 
isolated from the lesion in blood agar cultures overlaid with HBSS, and in CSDM isoenzyme, mAb 
and kinetocore DNA typing (R. D. Kreutzer, Youngstown  State  Univ., OH; D. MacMahon  Pratt 
and D. Wirth, Harvard Univ., Cambridge, MA, respectively) confirmed the isolate to be Lbb. Initial 
cultures  and those  subsequent  to a  full  course of antimony treatment  (Pentostain;  Burroughs- 
Wellcome, Beckenham,  United Kingdom) were positive. The patient was cured with Amphotericin 
B. Additional  clinical information on the patient is available. 
In addition,  it has been reported recently (16) that mAb and rabbit sera raised 
against promastigotes of one Leishmania species recognized similar surface deter- 
minants  in others. 
Herein,  we extend our initial observations on the 65,000 Mr glycoprotein, and 
show that it is a major surface determinant on both promastigotes and amastigotes 
of L. donovani (Ld), L. mexicana amazonensis (Lma), L. mexicana mexicana (Lmm), 
L.  major  (Ltm),  L.  braziliensis  guyanensis  (Lbg),  and  L.  braziliensis  braziliensis 
(Lbb).  Patients  convalescing  from  both  cutaneous  and  visceral  forms  of the 
disease contain antibodies that react with this determinant.  Finally, the glycopro- 
teins from various species exhibit strong homologies, as demonstrated by Cleve- 
land mapping,  physicochemical properties, and immunorecognition. 
Materials  and  Methods 
Parasites.  Nine different isolates of Leishmania were used in this study. Of these, seven 
have  been  characterized  by  at  least  three  of the  following  methods:  isoenzymes  (1), 
kinetoplast DNA buoyant density (2), mAb typing (4), and growth in phlebotomid sandflies 
(17). All have been characterized both by growth in blood agar (18) overlaid with Hanks' 
balanced salt solution (HBSS), and in complete Schneider's drosophila medium (CSDM) 
(Gibco Laboratories, Grand Island, New York) with  15% (vol/vol) heat-inactivated fetal 
bovine serum (HIFBS) (Hyclone, Sterile Systems Inc., Logan, UT) plus  100 U  penicillin 
and 100 t~g streptomycin per milliliter, in outbred golden hamsters (LVG:LAK, Lakeview 
Farms,  Wilmington, MA), and inbred  BALB/c/ByJ mice (The Jackson Laboratory, Bar 
Harbor, ME), and have been maintained as frozen stabilates in liquid nitrogen. The seven 
strains are listed in Table I. The Chinese strain of Ld (L. donovani infantum) was kindly 
provided  by Dr.  K.  P.  Chang,  Dept.  of Microbiology, Chicago Medical  School,  North 
Chicago, IL. The Brazilian strain of Ld (HB1) was isolated from a human case in Rio de 
Janeiro, and was obtained from Dr.  Mauro Marzochi (Fundacao Oswaldo Cruz,  Rio de 
Janeiro,  Brazil) (23).  Promastigotes of each species were cultured to stationary phase in 
CSDM  (5-7  d),  and  were  harvested  by  centrifugation  at  500  g  for  10  min  at  4°C. 
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Amastigotes were obtained from the macrophage celt line J774 1N-BALB/c (24), infected 
4 d previously with stationary phase promastigotes at a  10:1 parasite/cell ratio, except for 
Ltm, where  the cultures  were  infected  with  amastigotes obtained  from lesions.  These 
were purified from lesions at the base of the tail of BALB/c mice, which had been injected 
intradermally 8-12 wk previously with a 0.1  ml suspension containing 3 ×  10 7 primary 
culture  promastigotes  from  CSDM.  Lesions  were  aseptically  removed,  weighed,  and 
homogenized, as previously described (25).  Amastigotes were separated from tissues by 
centrifugation at 300 g for  10 min at 4°C.  The amastigote-containing supernatant was 
centrifuged at  1,000  g  to pellet the cells.  When  necessary, erythrocytes were lysed by 
adding freshly prepared 0.83%  NH4Cl for 3 min at 4°C, washing by centrifuging three 
times with 40 ml HBSS at  1,000 g  for  I0 min. Amastigotes thus obtained were >85% 
viable, as measured by Erythrosin  B dye exclusion (26).  The macrophage cell line was 
cultured in RPMI 1640 containing 10% (vol/vol) HIFBS, 2 mM glutamine, 25 mM Hepes, 
under  5%  COs  at  35°C,  at  an  initial  density  of  106  parasites/ml.  Amastigotes  were 
harvested by cooling the infected macrophages at 4 °C for 15 rain, scraping them with a 
rubber policeman, and centrifuging at 1,000 g for 10 min. At this time, no promastigotes 
were present. Cells were then lysed by exposure to 2 ml ofa hypotonic solution (42.5 mM 
KCI, 5 mM MgCI2) (27), and rapidly passing them seven times through a  23- and a  25- 
gauge needle. Osmotic pressure was restored by immediately raising the volume to 40 ml 
HBSS. Amastigotes were separated from lysed and intact macrophages by centrifugation 
at  1,000 g for  10  min at 4°C.  Parasites were resuspended in  5 ml HBSS and the total 
number of viable cells determined by Erythrosin dye exclusion in a Neubauer haemocy- 
tometer. 
Human Immune Serum.  Sera were obtained from eight patients hospitalized with Kala- 
azar (K) or cutaneous (tegumental)  Leishmaniasis (T).  These sera were the gift of Dr. 
Mauro Marzochi (Fundacao Oswaldo Cruz, Rio deJaneiro, Brazil). Patients were recruited 
from a local focus of infection (23), and clinical histories were available. Additional Kala- 
azar sera were obtained from six patients in East Africa (A), diagnosed as Kala-azar, but 
without detailed clinical documentation.  Sera were heat-inactivated (56°C  for 30  min) 
before incubation with live, biosynthetically labeled promastigotes. 
Cell Surface lodination.  Promastigotes were washed twice in HBSS by centrifugation 
at  500 g  for  10  rain.  Surface  iodination  was  performed as previously described  (28). 
Lactoperoxidase was purchased from Calbiochem-Behring Corp. (San Diego, CA); glucose 
oxidase (Type V) from Sigma Chemical Co. (St.  Louis, MO); Na~25I from New England 
Nuclear  (Boston,  MA).  After  iodination,  >95%  of the  parasites remained  viable and 
actively motile. Free 1~5I was eliminated by washing in HBSS. Cells were lysed in phosphate- 
buffered saline (PBS)  containing 0.5%  Nonidet  P-40 (Bethesda  Research Laboratories, 
Gaithersburg,  MD),  100  U/ml  aprotinin,  and  1  mM  phenylmethylsulphonyl  fluoride 
(Sigma Chemical Co.). 
Biosynthetic Labeling.  2 X 108 promastigotes were washed as above in HBSS. Parasites 
were then resuspended in 4  ml of Schneider's methionine-free medium (Gibco Labora- 
tories) supplemented with  15%  heat-inactivated fetal bovine serum (previously dialysed 
against PBS), and 150 #Ci of [35S]methionine (500 #Ci/mmol) (Amersham Corp., Arling- 
ton Heights, IL). After 12 h of incubation at 26°C, cells were washed in HBSS, aliquots 
of live 3~S-labeled parasites were removed for immunoprecipitation of surface components, 
and those remaining were lysed as described above. 
Immunoprecipitation.  Radiolabeled promastigote lysates were clarified by centrifuga- 
tion at 23,000 g for 20 min, at 4°C.  50-#l samples of the supernatants were incubated 
with  5  #1  of human  sera  for  1  h  at  4°C,  with  constant  agitation.  Antigen-antibody 
complexes were precipitated with 20 #1 of a 30% (vol/vol) solution of Protein A-Sepharose 
4 B in PBS, as previously described (29, 30).  Antigens were eluted in 50 #1 of electropho- 
resis sample buffer (2% sodium dodecyl sulfate [SDS],  12% sucrose, 0.01% bromophenol 
blue,  50  mM dithiotreitol,  and  50 mM  Na~CO3  buffer, pH 8.6) and boiled for 2  min. 
Samples were stored at -70°C until used. 
For isolation of [a~S]methionine-labeled surface components, live radiolabeled promas- 
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and incubated for 30 min at 4°C, with gentle agitation. After washing by centrifugation 
(500 g for 10 min), lysates were prepared, clarified by centrifugation (23,000 g for 20 
min), and immunocomplexes were isolated as above. 
Polyacrylamide Gel Electrophoresis (PAGE).  Radiolabeled proteins were electrophoresed 
in 1  -mm thick, 7.5 - 11% polyacrylamide  gradient slab gels (31). Gels of 35S-labeled proteins 
were processed for fluorography (32) and exposed on prefogged Kodak X-Omat R-1 film 
at -70°C. ~5I gels were autoradiographed using Kodak XAR-5 film with Dupont Cronex 
Lightning Plus intensification screens (Dupont Instruments, Wilmington, DE). 
Peptide Analysis.  Quintuplet samples of l~SI-labeled promastigotes were electropho- 
resed as described above. A  lane containing molecular weight standards was removed, 
stained briefly, and used as a reference to localize  the region between standards of Mr 
43,000-67,000 in the remaining gel. This section for each lane was cut into l-ram slices, 
which were subsequently counted in a gamma counter. The slices containing the highest 
number of counts per minute were used in a  modified Cleveland peptide map (34), as 
described by Piperno et al. (35). Briefly, the gel slices were placed in the sample wells of 
a second 7.5-15% polyacrylamide slab gel, without prior elution. The slices were previ- 
ously quickly immersed in a buffered solution (1  mM EDTA, 0.1%  SDS, and 0.05  M 
Tris/H2SO4, pH 5.8, with 0.0001% bromophenol blue), and pushed down the bottom of 
the sample wells. The wells were then overlaid with 10 #! of the same buffer containing 
20% glycerol, and finally 10 #1 buffer with 10% glycerol, to which appropriate amounts 
of S. aureus V8 protease (Miles Laboratories, Inc., Elkhart, IN) were added (0,  0.001, 
0.01, 0.1, or 1 #g/well). Electrophoresis was started, interrupted for a 75-rain incubation 
when the samples were focused at the interface between the stacking gel and the running 
gel, then continued until completion. 
Monoclonal Antibody.  mAb 6H12 (36) developed against L. mexicana amazonensis was 
kindly provided by Dr. K. P. Chang. 
Results 
Externally  Disposed  Polypeptides  of Leishmania  Promastigotes.  Promastigotes 
were surface-iodinated at mid-log growth phase, and the labeled peptides were 
then  subjected  to  7.5-11%  gradient  SDS-PAGE,  under  reducing conditions. 
The resulting pattern as seen in Fig. 1 for Lbb (Fig. 1, A  I), L. donovani HBI (B, 
I), and Ltm (C, I), shows that only a few surface components are labeled by this 
method. Among these, a peptide of Mr 65,000 is the most prominent band in all 
strains analyzed. This may occur in association with a  band of Mr 59,000  (not 
seen in this case). A 50,000-55,000 Mr band is seen with variable intensities, and 
it will be discussed below. A similar profile is found in all other species examined. 
It can also be  seen  in  Fig.  1 that, even when the gels are exposed  for longer 
periods of time, only a few additional bands of lower intensity are observed (Fig. 
1, A 3, B 3, and C 3) of Mr 45,000,  35,000,  32,000, and 20,000. 
Immunoprecipitation  by Convalescent  Sera from Patients with Cutaneous and Vis- 
ceral Disease.  Immunoprecipitation patterns using sera from patients with Kala- 
azar (K), or cutaneous disease (T) reveal a consistent pattern, demonstrating the 
recognition of the 65,000  Mr gp by all immune sera.  Some are represented in 
Fig.  1 (A 2, B 2, and C 2). The Kala-azar serum recognized the 65,000 Mr gp of 
Lbb less intensely than it did the homologous strain (Ld) or Ltm. This seems to 
be a  consistent finding. This indicates the immunogenicity of the 65,000 Mr gp 
in various clinical forms of the disease and in a worldwide distribution. 
Externally  Disposed  Polypeptides  of Leishmania  Amastigotes;  Surface  Iodination 
Profile.  Amastigotes obtained  from J774-infected  cultures  were  surface  iodi- 
nated, and the labeled peptides were analyzed in 7.5-11%  PAGE. Fig. 2 shows 906  COMMON  MAJOR  SURFACE  ANTIGEN  OF  LEISHMANIA 
FIGURE  1.  Surtace iodination and immunoprecipitation profiles of Leishmania species pro- 
mastigotes under reduced conditions. A, Lbb; B, Ld HB1; C, Ltm. Lane 1, Autoradiographic 
pattern  of whole cell lysate (6-h exposure); lane 2, immunoprecipitation of each strain  with 
convalescent sera from Brazilian patients with visceral leishmaniasis; lane 3, as in 1, but with a 
48-13 autoradiographic exposure. 
the resulting pattern for Lma (Fig. 2 b), Lmm (c), Lbg (d), and Ltm (e). As with 
promastigotes, the surface profile reveals relatively few surface components, and 
the major peptide displays an Mr of 65,000. The associated band at 59,000 Mr is 
seen with variable intensities in the different isolates, as is the 50,000 Mr.  Fig. 
2a  shows  the  profile  of an  iodinated  sample  that  consisted  of a  preparation 
obtained under the same experimental conditions, but prepared from an unin- 
fected  J774 culture. Fig. 2fshows the immunoprecipitation pattern of the sample 
of Fig.  2e (Ltm), when exposed to a serum obtained from one of the Kala-azar 
patients from East Africa (A6). 
Cleveland Map Profile of the 65,000 Mr gp in Promastigotes of  Different Leishmania 
Species.  We further evaluated the seeming identity of the 65,000 Mr gp of the 
different Leishmania species by Cleveland maps. The proteins were cut from gels 
and digested with increasing concentrations of V8 protease. The peptides result- 
ing from such digestion were analyzed by 7.5-15%  SDS-PAGE and the patterns 
obtained are shown in  Fig.  3.  Under the experimental conditions used in the 
assay, enzyme concentrations of as little as 0.001  ~g per sample initiate proteol- 
ysis,  generating peptides of Mr 48,000,  33,000,  and  22,000.  A  comparison of 
Fig.  3 A-D reveals the strong homology between the different Leishmania gp, 
where Fig. 3A is Lbg, B is Ltm, C is Ld (Khartoum), and Fig. 3D is Ld (HB1). 
Similar  results  were  bbtained  for  Lmm  and  Lbb  (not  shown).  The  striking 
homology patterns and the microheterogeneities observed among the different COLOMER-GOULD ET  AL.  907 
FIGURE 2.  Surface  iodination and immunoprecipitation  profiles of Leishmania species amas- 
tigotes purified from infected J774 cells. A, Mock-purified  amastigotes from uninfected  J774 
cells; B, amastigotes from Lma; C, Amastigotes from Lmrn; D, Amastigotes from Lbg; E, 
Amastigotes from Ltm;  F, lmmunoprecipitation of E with an East African Kala-azar  patient's 
immune serum. 
species and isolates are suggestive of a basic peptide core and possible differences 
in glycosylation. 
Surface  Profile  under Incomplete  or Nonreducing  Conditions,  and  Variability  of 
Labeled  Peptide  Pattern.  The  surface  profile  for  several  Leishmania  species 
described  in  previous  reports  (37-42)  revealed  considerable  variability  and 
complexity. These results could be explained by two of our findings. The first is 
the shift initially observed for the  Ld 65,000  Mr gp to an Mr of 50,000  under 
nonreducing conditions (7).  This is seen in Fig. 4, where under reduced condi- 
tions (Fig. 4A), the major iodinated surface component is seen as a  65,000  Mr 
band.  Under nonreducing conditions (C),  the same sample is seen as a  50,000 
Mr band. However, under partially reduced conditions (i.e., reducing agent not 
added  immediately before  running the  sample),  a  range  of bands is  observed 
between  65,000  and  50,000  Mr.  It is also seen that the recognition by human 
immune serum  (Kala-azar serum,  KI) is  preserved  under all  three  conditions. 
This is further documented in  Fig.  5  for other Leishmania  species.  Incomplete 
reduction leads to the appearance of a complex pattern of bands (Fig. 5, part/). 
This can be seen in A for Lmm, where most of the label is seen at 50,000 Mr, in 
B for Ld HB1, in C for Lbg (wild type) and in D for Lbg (clone 8-3).  In the last 
three, a number of bands occur, ranging from 65,000 to 50,000 Mr. Fig. 5, part 
H  illustrates the surface pattern of the same isolates under nonreducing condi- 
tions.  In  this case,  all  of the  65,000  Mr gp  has shifted to Mr  50,000,  and  the 908  COMMON  MAJOR  SURFACE  ANTIGEN  OF  LEISHMANIA 
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FIGURE 4.  Surface iodination profile of Ld HB1 under completely reduced conditions (A), 
incompletely reduced conditions (B), and nonreducing conditions (C). The left panel shows 
the patterns for whole cell lysates; right panel shows the pattern for immunoprecipitates 
obtained with serum from a Brazilian Kala-azar patient (patient 1). 
surface-labeled profile is much simpler.  The reason for these differences is not 
yet understood.  Fig.  6  shows for other Leishmania  species that  recognition  by 
human immune serum (K and T) is not affected by the nonreducing conditions. 
Identity of the 50,000 Mr gp with the 65,000 Mr gp is further supported by its 
recognition  using  mAb  6H12  which  recognizes  a  glycopeptide  triplet  of Mr 
65,000-68,000  in  Lma  (36)  (Fig.  6  M).  Interestingly,  the  same mAb strongly 
recognizes the 50,000 Mr component in L. donovani infantum, under nonreducing 
conditions. 
The second of our findings, which could explain some of the complex patterns 
described in previous reports (36-41), refers to the different cellular fragility of 
the several Leishmania species. Mechanical damage during the course of centrif- 
ugation leads to endoproteolysis of the Mr 65,000 gp, and optimal experimental 
conditions vary from one species to another.  In Fig. 6, the immunoprecipitates 
show the recognition  of components of Mr 20,000,  32,000,  and 35,000,  which 
may be represented at variable intensities from experiment to experiment. These 
seem to result from various degrees of endoproteolysis, on the basis of homologies 
found by peptide map analysis (data not shown). 910  COMMON  MAJOR  SURFACE  ANTIGEN  OF  LEISHMANIA 
FIGURE 5.  Surface iodination profile of Leishmania species promastigotes under conditions 
of incomplete reduction (/) or nonreducing conditions (I/). A, Lmm; B, Ld HB1; C, Lbg (wild 
type); D, Lbg clone 8-3. 
Biosynthetic Labeling  of Promastigotes of Leishmania  Species.  To  establish  the 
parasite origin  of the major iodinated polypeptide, and  to confirm  its external 
disposition  on  the  parasite  surface,  promastigotes  of the  different  Leishmania 
isolates were labeled with [SSS]methionine. The live, labeled organisms were then 
incubated  with  human  immune  serum  at  4°C,  washed  to  remove  unbound 
antibodies, lysed, and the immunocomplexes were isolated and analyzed in SDS- 
PAGE. Fig. 7 highlights these results for Lbg. The incorporation of label in the 
total lysates is seen in Fig. 7 C. This contrasts both with the immunoprecipitation 
by a  human  immune  serum from an African  Kala-azar  patient,  which binds to 
only a few of these labeled components, in particular a band of Mr 65,000 (Fig. 
7B), and with normal  human  serum,  which precipitates no bands (A). Identical 
results  were  obtained  with  all  other  species of Leishmania  tested  (not  shown). 
These data agree with previous results for Ld (7). 
Discussion 
This study was aimed at comparing the polypeptide surface profile of amasti- 
gotes and promastigotes of several Leishmania  species and to characterize  those 
that were recognized by antibodies in sera from convalescent patients.  Previous 
work  from  this  laboratory  (7)  had  provided  evidence  that  the  major  surface 
glycoprotein  of Ld  promastigotes  was  recognized  by sera  from  patients  with 
clinical  forms of Leishmaniasis  other than  Kala-azar,  suggesting that  this  same 
antigen might be common to other Leishraania species. COLOMER-GOULD ET  AL.  911 
FmURE 6.  Immunoprecipitation  profiles of Leishmania species promastigotes under nonre- 
ducing conditions.  Ld-2, Ld infantum; K and T as described in Materials and Methods. NS, 
normal human serum; M, monoclonal  antibody  6H12. 
Using surface radioiodination, we have now shown that the exteriorly disposed 
glycopeptide profile of amastigotes and promastigotes of six different species of 
Leishmania  are  remarkably  similar,  and  display  as  the  major  determinant  a 
glycoprotein of Mr 65,000.  This component was a  potent immunogen in man 
and was recognized by sera from patients with homologous as well as heteroiogous 
infection. In addition, we have provided evidence that the major 65,000 Mr gp 
in the different Leishmania  species is not only similar in Mr and in displaying 
crossreactive epitopes, but also homologous in molecular nature. The evidence 
relies on two parameters: (a) behavior under reducing and nonreducing electro- 
phoretic conditions, and (b) Cleveland mapping. Indeed, we have observed, in 
all  species  and  isolates  examined,  the  same  shift  in  the  major  immunogenic 
determinant from  65,000  to  50,000  Mr  under  nonreducing conditions.  The 
oresence of a  sporadic band at Mr 50,000  in  the reduced gels may represent 912  COMMON  MAJOR  SURFACE  ANTIGEN  OF  LEISHMANIA 
FIGURE 7.  Biosynthetic labeling of promastigotes  of Lbg  with  [3SS]methionine.  A  and  B: 
lmmunoprecipitation of live labeled parasites incubated with normal human serum (A) or with 
an  East African Kala-azar patient's serum (patient  A6) (B). C,  Incorporation of label in  the 
total parasite lysate. 
incomplete reduction  of sulfhydryl groups or,  as  will  be  discussed below,  the 
result of some degree of endoproteolysis in the samples. V8 protease Cleveland 
maps of the major iodinated band revealed a nearly identical peptide pattern for 
all Leishmania species, indicating the homologies in the molecular nature of the 
65,000 Mr gp. The major peptides generated by partial V8 proteolysis (48,000, 
33,000, and 22,000 M 0 are frequently observed in the surface iodination profiles 
when care is not taken to avoid proteolysis. This is in keeping with some divergent 
results in the literature, which display ~uite complex and distinct surface profiles 
for different Leishmania species (36-4~6).  In sample handling, therefore, several 
points should be stressed: (a) the fragility of the cells during the washing steps, 
which will result in cell damage,  release of lysosomal enzymes and endoprote- 
olysis, with some Leishmania species being more susceptible to mechanical damage 
than others,  (b) the necessity of keeping the samples at 4°C in the presence of 
protease inhibitors, and (c) the need to insure proper reduction of the samples. 
Our data are apparently contrary to most of the available evidence and concept 
in  terms of Leishmania  surface  antigens,  their  species  uniqueness, and  role  in 
producing disease and/or immunity. On the other hand, it can be well reconciled 
with the majority of the available data (6,  36-41) when analyzed in the light of 
the  above  findings.  A  major  surface  protein  so  conserved among Leishmania 
species must fulfill an important biological role in the host-parasite interaction. COLOMER-GOULD  ET  AL.  913 
The different biological behavior of different Leishmania species and isolates, as 
well as  their precise immunological specificities, could still  be adequately ex- 
plained by different glycosylation of the same core peptide. 
Biosynthetic labeling  with  [SSS]methionine and immunoprecipitation of the 
live organisms with human immune sera revealed that, among the predictably 
high number of proteins labeled, the major protein accessible to the sera and, 
therefore, on the surface, was the 65,000 Mr gp. The glycoprotein nature of this 
polypeptide has been determined by us (7, 8) and others (36, 39, 41) on the basis 
of its specific binding to Con A. 
Undoubtedly, there are surface components characteristic for each species and 
even isolates of Leishmania, but those seem to represent minor determinants (4- 
6). The striking feature demonstrated here is the similarity, rather than differ- 
ences, among all the Leishmania species examined. These are all human pathogens 
isolated from worldwide cases of human disease. The recognition of the major 
surface component by sera from patients with all forms of Leishmaniasis indicates 
its role as the immunodominant antigen in Leishmania species. 
The presence of crossreactive determinants in Leishmania stocks has long been 
known. Serological crossreactivities have been observed by many immunological 
techniques, including the generation of mAb (4,  5,  42,  43).  In the latter,  the 
majority of antibodies obtained crossreact with most species, rather than showing 
species specificity. Crossprotection, although not the rule, has been extensively 
demonstrated both in human and experimental infections (9-15).  Of particular 
relevance are the results of Howard and coworkers (13-15), where prophylactic 
immunization of mice with irradiated promastigotes of Ltm induced protection 
and long-lasting immunity effective against both promastigote and amastigote 
challenges, and  detectable not only against  Ltm but also  Lmm,  Lma, and L. 
braziliensis panamensis.  In addition, substantial protection could also be induced 
by irradiated promastigotes of Ld. These resuhs are in keeping with the existence 
of common major surface determinant(s) present in promastigotes and amasti- 
gotes of all Leishmania species, which results in induction of protective immunity. 
Although other authors (13-15)  have established that the resulting protective 
immunity is not mediated by antibodies, it is likely that the same immunogenic 
determinants are involved in induction of the protective cell-mediated responses. 
As we have previously suggested (7, 8), small differences in glycosylation could 
account for the differences in immunorecognition and biological behavior ob- 
served among Leishmania species. An assessment of the role of the 65,000 Mr gp 
in the induction of protective immunity to Leishmania infection is presently being 
investigated. 
Summary 
Enzymatic surface iodination and biosynthetic labeling with [35S]methionine, 
combined with immunoprecipitation by sera from patients with different forms 
of Leishmaniasis revealed a  65,000  Mr glycoprotein as  the immunodominant 
moiety in  promastigotes and  amastigotes  of the nine  Leishmania  species and 
isolates examined. Sera from patients with one form of Leishmaniasis recognized 
this component strongly, not only in the homologous, but also in the heterologous 
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In  addition  to the  crossreactivity displayed by immune  sera,  the  65,000 Mr 
glycoprotein (gp)  common  to  all  Leishmania  species  presented a  characteristic 
shift to Mr 50,000 when samples were run in sodium dodecyl sulfate-polyacryl- 
amide  gel  electrophoresis under  nonreducing conditions.  These results are  in 
agreement with our previous studies (7), where a simple and similar profile was 
obtained  for several  geographic  isolates  of L.  donovani,  with  a  major  surface 
glycoprotein of 65,000 Mr displaying the same characteristics described here. 
The  structural  similarity  of the  major  65,000  Mr  gp  of the  six  Leishmania 
species was demonstrated by Cleveland mapping.  It is suggested that immuno- 
logical specificities may be contributed by minor differences in glycosylation of 
this molecule. In keeping with recent data (I 3-15), where strong crossprotection 
among different Leishmania species has been obtained by prophylactic immuni- 
zation  with  irradiated  whole  promastigotes,  this  glycoprotein may  be  a  good 
candidate  for  an  antigen  to  be  used  for  immunoprophylaxis  of all  forms  of 
Leishmaniasis. 
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George Cross for critically reading the manuscript, and Dr. Z. A. Cohn for his support, 
advice, and critical reading of the manuscript. 
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